date,title,source
Oct-24-18,"Compugen Third Quarter 2018 Conference Call Scheduled for Wednesday, November 7, 2018 at 8:30 AM ET",PR Newswire
Nov-05-18,Compugen Ltd. (CGEN) Sees Hammer Chart Pattern: Time to Buy?,Zacks
Nov-07-18,Compugen (CGEN) Reports Q3 Loss,Zacks
Nov-07-18,Compugen: 3Q Earnings Snapshot,Associated Press
Nov-07-18,Compugen Reports Third Quarter 2018 Results,PR Newswire
Nov-13-18,"Compugen Announces Issuance of U.S. Patent for COM902, Its TIGIT Antibody Product Candidate for Cancer Immunotherapy",PR Newswire
Nov-23-18,"New Research Coverage Highlights Vulcan Materials, Cimpress N.V, Asterias Biotherapeutics, ElectraMeccanica Vehicles, Compugen, and China HGS Real Estate  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Jan-14-19,Compugen's Phase 1 Trial of COM701 Featured as a Trial-in-Progress at The ASCO-SITC Clinical Immuno-Oncology Symposium,PR Newswire
Jan-16-19,How Much Of Compugen Ltd. (NASDAQ:CGEN) Do Institutions Own?,Simply Wall St.
Jan-22-19,Compugen Announces Publication of Two Peer-Reviewed Papers Demonstrating the Role of PVRIG as a Novel Immune Checkpoint for Cancer Immunotherapy,PR Newswire
